You may also notice other side effects common with CNS stimulants, like tremors and increased heart rate
GLP-1RAs dominate IGE-related reports Among the top 10 drugs associated with IGE events, five were GLP-1 receptor agonists: Dulaglutide: 262 cases Semaglutide: 246 cases Exenatide: 183 cases Tirzepatide: 181 cases Liraglutide: 110 cases Together, they accounted for 49.5% (982 of 1982) of the IGE reports among these top 10 drugs
However, results vary based on your gut and you may begin to feel some benefits in Month 1-2
Total daily dose: Weeks 14 at 500 mcg total , then Weeks 58 at 1000 mcg total , once daily (or 5 days on, 2 off)
Some patients use GLP-1 therapy for short term results, while others continue with long-term maintenance to reduce the risk of weight regain
Comunicados da Eli Lilly (27 de julho de 2023) relatam que tirzepatida, um agonista duplo GIP/GLP1, proporcionou perda mdia de 26,6 % do peso aps 84 semanas